INTRODUCTION TO THE MARKET
When cells in the prostate gland begin to develop unnaturally and uncontrolled, it is called prostate cancer. The prostate is a gland found solely in males that produces some of the fluid found in sperm. Surgery, radiation, hormone therapy, chemotherapy, and other treatments are available for prostate cancer. Prostate cancer therapy is determined on the stage of the disease. Prostate cancer is treated by experts such as urologists, radiation oncologists, and medical oncologists.
MARKET DYNAMICS
The prostate cancer treatments market is expected to expand throughout the projected period, owing to factors such as increased prevalence of prostate cancer in North America, Asia Pacific, and other countries. The growing elderly population throughout the world is driving market growth over the predicted period. Healthcare advancements and cancer discoveries are projected to generate growth possibilities during the predicted period.
MARKET PERSPECTIVE
The "Global Prostate Cancer Therapeutics Market Analysis to 2028" report is a specialised and in-depth examination of the pharmaceutical business, with a particular emphasis on worldwide market trend analysis. The purpose of this study is to give an overview of the prostate cancer therapeutics market, as well as extensive market segmentation by therapy, distribution channel, and geography. During the forecast period, the global prostate cancer therapeutics market is expected to grow rapidly. The research contains important information on the market position of the major prostate cancer therapies industry companies, as well as key market trends and opportunities.
MARKET SEGMENTATION
The worldwide prostate cancer therapies market is divided into therapy area and distribution channel segments. The sector is divided into four categories according on the therapy: hormone therapy, chemotherapy, targeted therapy, and immunotherapy. The category is classified into hospitals, specialist clinics, and others based on the distribution channel.
REGIONAL ANALYSIS
The paper offers a comprehensive overview of the sector, including both qualitative and quantitative data. It offers an overview and forecast of the worldwide prostate cancer therapies market by segment. It also gives market size and projection estimates for North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America from 2020 to 2028. The prostate cancer therapies market is further subdivided by area, country, and segment. The research analyses and forecasts 18 nations internationally, as well as existing trends and prospects in the region.
The research examines variables influencing the prostate cancer therapies market from both the demand and supply sides, as well as key dynamics influencing the market over the forecast period, such as drivers, constraints, opportunities, and future trends. The research also includes a comprehensive PEST analysis for each of the five regions, including North America, Europe, APAC, MEA, and South & Central America, after assessing the political, economic, social, and technical variables influencing the prostate cancer treatments market in these areas.
MARKET PARTICIPANTS
Articles cover significant changes in the prostate cancer therapy industry as well as organic and inorganic growth methods. Different companies focus on organic growth strategies like product launches, product approvals, and other things like patents and events. Acquisitions along with partnerships and collaborations were some of the inorganic growth tactics seen in the industry. These initiatives have paved the way for market players to grow their business and customer base. Considering the increased demand for prostate cancer therapies in the global industry, payers of the prostate cancer therapies market are expected to enjoy attractive growth prospects in the future. The list below identifies some companies involved in the prostate cancer treatment industry.
The report also includes the profiles of key prostate cancer therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
• Valent Pharmaceuticals LLC
• Bayer AG
• Astrazeneca
• Sanofi Aventis
• IPSEN
• Bristol-Myers Squibb
• Astellas Pharma Inc
• Pfizer Inc
• Teva Pharmaceutical Industries Ltd
• Abbott Laboratories
-
Introduction
-
Definition of Prostate Cancer Therapeutics Market
-
Scope of the Report
Methodology
-
Executive Summary
-
Market Overview
-
Market Definition and Segmentation
-
Market Dynamics
-
Drivers
-
Restraints
-
Opportunities
-
Porter's Five Forces Analysis
-
PESTEL Analysis
Prostate Cancer Therapeutics Market, By Therapy:
-
Hormonal Therapy
-
Chemotherapy
-
Targeted Therapy
-
Immunotherapy
Prostate Cancer Therapeutics Market, By Distribution Channel:
-
Hospitals
-
Specialty Clinics
-
Others
Prostate Cancer Therapeutics Market, By Geography
-
North America
-
United States
-
Canada
-
Europe
-
United Kingdom
-
Germany
-
France
-
Spain
-
Italy
-
Rest of Europe
-
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Rest of Asia-Pacific
-
Latin America
-
Brazil
-
Mexico
-
Rest of Latin America
-
Middle East & Africa
-
Saudi Arabia
-
United Arab Emirates
-
South Africa
-
Rest of Middle East & Africa